| Literature DB >> 34069870 |
Diego Lucas Neres Rodrigues1, Francielly Morais-Rodrigues1, Raquel Hurtado1, Roselane Gonçalves Dos Santos1, Daniela Camargos Costa2, Debmalya Barh1,3, Preetam Ghosh4, Khalid J Alzahrani5, Siomar Castro Soares6, Rommel Ramos7, Aristóteles Góes-Neto1, Vasco Azevedo1, Flávia Figueira Aburjaile1.
Abstract
Acinetobacter baumannii is an important Gram-negative opportunistic pathogen that is responsible for many nosocomial infections. This etiologic agent has acquired, over the years, multiple mechanisms of resistance to a wide range of antimicrobials and the ability to survive in different environments. In this context, our study aims to elucidate the resistome from the A. baumannii strains based on phylogenetic, phylogenomic, and comparative genomics analyses. In silico analysis of the complete genomes of A. baumannii strains was carried out to identify genes involved in the resistance mechanisms and the phylogenetic relationships and grouping of the strains based on the sequence type. The presence of genomic islands containing most of the resistance gene repertoire indicated high genomic plasticity, which probably enabled the acquisition of resistance genes and the formation of a robust resistome. A. baumannii displayed an open pan-genome and revealed a still constant genetic permutation among their strains. Furthermore, the resistance genes suggest a specific profile within the species throughout its evolutionary history. Moreover, the current study performed screening and characterization of the main genes present in the resistome, which can be used in applied research to develop new therapeutic methods to control this important bacterial pathogen.Entities:
Keywords: antimicrobial; drug resistance; multilocus sequence typing; nosocomial infections; pan-genome
Year: 2021 PMID: 34069870 PMCID: PMC8157372 DOI: 10.3390/antibiotics10050596
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Figure 1Graphical representation of the global distribution of isolation sites of different strains of Acinetobacter baumannii in a grouped way. The colors represent the sequence types of the strains in this study. The size of the circle indicates the number of isolated strains.
Figure 2Phylogenomic tree based on the core genome of 206 Acinetobacter baumannii strains. The colors represent the grouping by sequence type. The method used was maximum likelihood with statistical support of 1000 bootstraps with 1999 genes present in the core genome.
Figure 3Representation of the circular genome of the A. baumannii AYE strain as a central genome. The compared strains were grouped and colored.
Figure 4Development curve of the pan-genome of Acinetobacter baumannii.
Figure 5Graphical representation of the gene distribution by metabolic pathway within each subpartition of the total pan-genome. Only pathways with at least 0.1% of the genes represented in each subpartition of the pan-genome were considered.
Description of the genes present in the core resistome of the studied strains containing the mechanisms of action and antibiotics associated with these mechanisms [11].
| Gene | Definition | Mechanism | Antibiotic |
|---|---|---|---|
| adeK | The outer membrane factor protein in the adeIJK multidrug efflux complex | Antibiotic efflux | Phenicol, rifamycin, penem, diaminopyrimidine, tetracycline, carbapenem, macrolide, lincosamide, floroquinolone, cephalosporin |
| adeJ | An RND efflux protein that acts as the inner membrane transporter of the AdeIJK efflux complex | Antibiotic efflux | Diaminopyrimidine, phenicol, tetracycline, rifamycin, carbapenem, penem, fluoroquinolone, macrolide, cephalosporin, lincosamide |
| adeI | The membrane fusion protein of the AdeIJK multidrug efflux complex | Antibiotic efflux | Phenicol, rifamycin, penem, diaminopyrimidine, tetracycline, carbapenem, macrolide, lincosamide, floroquinolone, cephalosporin |
| adeF | The membrane fusion protein of the multidrug efflux complex AdeFGH | Antibiotic efflux | Tetracycline, fluoroquinolone |
| adeG | The inner membrane transporter of the AdeFGH multidrug efflux complex. | Antibiotic efflux | Tetracycline, fluoroquinolone |
| adeL | A regulator of AdeFGH in | Antibiotic efflux | Tetracycline, fluoroquinolone |
| ampC | AmpC type beta-lactamases are commonly isolated from extended-spectrum cephalosporin-resistant Gram-negative bacteria. | Antibiotic inactivation | Cephalosporins |
| adeN | AdeN is a repressor of AdeIJK, an RND-type efflux pump in | Antibiotic efflux | Carbapenem, diaminopyrimidine, rifamycin, penem, tetracycline antibiotic, phenicol, lincosamide, fluoroquinolone, cephalosporin, macrolide |
| abeM | AbeM is a multidrug efflux pump found in | Antibiotic efflux | Acridine dye, fluoroquinolone antibiotic, triclosan |
Figure 6Distribution of the resistance mechanisms related to each antimicrobial found in the database used in the predicted total pan-resistome.
Figure 7Distribution of the resistance mechanisms related to each type of action provided by the translated protein.